Evercore ISI Group Initiates Coverage On Cardlytics With In-Line Rating, Announces Price Target of $4
Evercore ISI Group Initiates Coverage On Cardlytics With In-Line Rating, Announces Price Target of $4
Evercore ISI集团发起对cardlytics的覆盖，给予内险评级，并公布4美元的目标价。
Evercore ISI Group analyst Mark Mahaney initiates coverage on Cardlytics (NASDAQ:CDLX) with a In-Line rating and announces Price Target of $4.
Evercore ISI Group分析师Mark Mahaney对Cardlytics（纳斯达克:CDLX）发起覆盖，给予一致评级，并宣布目标股价为$4。
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
资讯热榜
更新时间